Patients with bladder cancer needed for a research study of two immunotherapy drugs (derazantinib and atezolizumab)

The UVA Cancer Center seeks adults ages 18 and over with urothelial (bladder) cancer for a clinical trial. The purpose of this study is to evaluate a chemotherapy drug (enfortumab vedotin) alone or in combination with other anticancer therapies in patients with urothelial cancer. Disease response and good and bad effects of the drug will be studied as part of this study. Study specific tests will be provided at no cost to you.

Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT03288545